Are medical oncologists in Canada willing to learn about a new genetic tumour test and discuss it with patients?
How many patients would be ideal candidates for this test from a clinical and private insurance perspective?
The client can proceed with a medical education strategy that targets a broad array of medical oncologists. Communication will focus on specific stages of the patient journey and the data that support the new test’s use in these stages. The pricing insight also helps forecast the size of the market opportunity.
Contact KeyOps to learn how our engaged network of physicians can provide you the insight you need to build your growth strategy with confidence.